Artificial joints are a large class of products in orthopaedic devices. They are implantable artificial organs designed to save the joints that have lost their functions. They belong to the three types of medical devices in China. At present, artificial joints are mainly divided into artificial knees, hips, elbows, shoulders, fingers, toes and joints, of which the products with larger market sales are artificial knee joints and artificial hip joints. The number of artificial joint replacements accounts for almost all of the artificial 90% of the amount of joint replacement.
Market prospects <br> <br> Currently, artificial joint replacement surgery have a more mature operation, it can eliminate joint pain, joint function return to normal activities, so that people affected by long-term joint pain and suffering of a new life again, surgery Afterwards, walking, traveling, working and physical exercises can be performed like normal people, so artificial joints have become one of the major best-selling products in the orthopedic device market.
Joint disease is a common disease in the elderly. Through joint replacement surgery, many elderly people have regained confidence in life and have effectively improved their quality of life. As the global population ages, the demand for artificial joints is increasing. At the same time, the number of joint traumas caused by intense sports and traffic accidents is increasing every year. The demand for artificial joint products required for treatment is increasing day by day, and the artificial joint market is developing at an unprecedented rate.
With the development of science and technology, artificial joint materials have evolved from early wear-resistant stainless steel joints to today's high-performance materials such as silicon carbide and other high-hardness ceramic materials, aerospace ceramic materials, and aluminum-zirconium alloy materials. The artificial joints made of these high-performance materials have made the hardness, wear resistance, impact resistance, high temperature stability and biocompatibility of the products greatly improved. The weight is closer to the bones and joints, and the compatibility with the human body is even greater. it is good. The continuous improvement of safety and effectiveness further promotes the widespread use of artificial joints.
Quality of domestic products is expected to increase <br> <br> from the domestic market share of view, according to incomplete statistics, in 2011 China's orthopedic surgeon has implemented a total of about 200,000 cases of arthroplasty, in this process, hospitals are more Products of foreign companies such as Johnson & Johnson, Zimmer and Xerox. At present, imported products account for more than 60% of the market share of artificial joints in China.
Compared with domestic products, the functionality and effectiveness of imported products are higher, but the price is relatively expensive, the price is often 2 to 3 times that of similar domestic products, such as domestic artificial hip joints price of about 20,000 to 30,000 yuan , imports are 40,000 to 50,000 yuan. From the perspective of clinical application, some imported products are designed according to the anatomical and physiological characteristics of European and American races, and there is a problem of mismatching with patients' bones in clinical applications in China. This will increase the difficulty of operation and increase the time, and increase the number of doctors and patients. Risk, to a certain extent, affects the effectiveness of clinical treatment.
In June 2011, the “12th Five-Year Plan†national high-tech research and development program in the field of new materials technology “The research and development of key materials technology for the replacement and repair of typical human organ tissues†has been approved by the Ministry of Science and Technology. The project content includes the titanium alloy artificial Key technologies and product R&D for joints and traumatic materials are designed to break through the key technologies of design, processing, surface modification and large-scale production to develop economical, practical and reliable products that meet the physiological characteristics of Chinese people and reduce product prices. Fully independent intellectual property rights artificial joint industry chain.
The development of local brands has continued since 2000. With the rigid demand of the market, the market for artificial joints in China has grown rapidly. Local companies have already achieved the first step of differentiation in the early stages, and a number of representative companies have emerged, such as Chuangsheng, Kanghui and Weiwei. These companies are based on The mid-end market gradually penetrates the high-end market and continues to extend its product lines to overseas markets.
At present, on the one hand, China's artificial joint production enterprises should increase research and development efforts, strengthen cooperation with universities and research institutions, and jointly apply for government support and support in funds and policies, and strive to establish new materials and new processes in the product. Advantages; On the other hand, companies should listen to doctors and patients' suggestions and opinions, encourage them to directly participate in product development, and make products more in line with patient characteristics and disease characteristics. At the same time, the protection of intellectual property rights has been strengthened, and on the basis of ensuring that independent brands are not harmed, and using the price competition of their own products and geographical location advantages, they have actively explored markets in Africa and Asia and established long-term cooperative relationships with medical institutions in some countries. The market takes the initiative.
Artificial joint global growth in foreign trade flat <br> <br> In recent years, artificial joint global trade import and export growth rate is very rapid. From 2007 to 2011, the average annual growth rate of artificial joint imports was 11.02%, and the average annual growth rate of exports was 12.4%.
From the perspective of importing countries, in 2011, a total of 13 countries had imported more than 100 million U.S. dollars, namely the United States, Germany, Belgium, France, Japan, Switzerland, Italy, the Netherlands, the United Kingdom, Australia, Spain, Canada, and South Korea. From the perspective of exporting countries, a total of nine countries in the world have exported more than 100 million U.S. dollars, including the United States, Belgium, Germany, Switzerland, Ireland, France, the United Kingdom, the Netherlands, and Italy.
The first half of 2012 exports of artificial joints <br> <br> Belgium is the largest export market for the region, China's exports to the amount of artificial joints Europe amounted to $ 34.068 million, 91.57% of the total amount for the first outlet market. From the perspective of specific countries and regions, China has exported artificial joints to 32 countries and regions. The total value of the top ten trading partners reached US$36.735 million, accounting for 98.74%. Belgium is China's first export partner, and its export value reached 270.707 million US dollars, accounting for 72.76% of the total amount.
Jiangsu's exports account for 80%. From the perspective of exporting provinces and cities, China's provinces and cities that export artificial joints are relatively concentrated, and only 8 provinces and cities export artificial joints. Although only three companies in Jiangsu Province ranked first in terms of export value, their total exports amounted to US$ 29.9089 million, accounting for 80.12% of the national export volume, reflecting the high degree of concentration in export regions. From the perspective of growth rate, the growth rates in Beijing, Henan, and Guangdong are more obvious.
Foreign-funded enterprises are the main force for exports. Among the 31 companies that engage in artificial joint export trade, 12 are foreign-funded enterprises with an export value of 35,548,900 U.S. dollars, accounting for 95.55% of the total export value; 12 private enterprises, export value of 0.959 million U.S. dollars, accounting for the total 2.58% of the export value; seven state-owned enterprises, the export value of 69.55 million US dollars, accounting for 1.87% of total exports.
The first advantage is that the export value of the top ten enterprises in the export market totals US$3,603.03 million, accounting for 97.6% of the total export value. Among them, the number one exporter of Johnson & Johnson (Suzhou) Medical Equipment Co., Ltd. has exceeded US$20 million in export volume. Far more than other companies. Among the remaining 30 companies, only Xi'an Antai Blade Technology Co., Ltd., Changzhou Baomeite Medical Devices Co., Ltd. and Linker Orthopedics (China) Co., Ltd. have exported more than US$1 million.
Increase in the Import Volume of Imported Artificial Joints in China From 2007 to 2011, the import and export trade of artificial joints in China witnessed a rapid development. The export value increased from US$3.834 million to US$51.72 million, and the import value increased even more, from US$60.943 million to US$131 million. The trade deficit widened from 57.109 million US dollars to 79.646 million US dollars. From January to June 2012, China's artificial joint import and export volume reached 143 million U.S. dollars, of which export value was 37.2304 million U.S. dollars, an increase of 56.76% year-on-year, and import value was 106 million U.S. dollars, an increase of 46.43% year-on-year.
The first half of 2012, imports of artificial joints <br> <br> United States and Germany are the two major import markets of Europe and North America from imported artificial joint amounted to $ 42,394,500 and $ 56,400,900, respectively of the total imports of 40.03% And 53.26%.
From the perspective of specific countries and regions, China has imported artificial joint products from 17 countries and regions. The United States, Germany and Switzerland are the main import trading partners. From the perspective of growth rate, the growth rates of the United States and Switzerland are significant, reaching as high as 120.31% and 125.52% respectively.
Shanghai's imports ranked first. From the perspective of imported provinces and cities, Shanghai, Beijing, Jiangsu, Sichuan, Hubei, Guangdong, Henan, Shandong, and Liaoning have imported artificial joints in 9 provinces and cities. The total import value of 25 enterprises in Shanghai totaled 74,190,300 US dollars, and the number and amount of imported companies ranked first in the country.
Foreign-funded enterprises as import leaders China has a total of 58 companies engaged in artificial joint import trade, including 24 foreign-funded enterprises, with an import value of 77.537 million US dollars, accounting for 73.22% of the total import value; 12 state-owned enterprises, import value of 23.7747 million US dollars, accounting for the total 22.45% of the import value; 22 private enterprises, with an import value of 4,599,100 USD, accounting for 4.33% of the total import value.
The top ten largest importers of the top four companies imported a total of US$90.1313 million worth of imports, accounting for 90.67% of the total imports. Johnson & Johnson (Shanghai) Medical Equipment Co., Ltd., Beijing Wei Lian De Orthopedics Technology Co., Ltd., Zimmer (Shanghai) Medical International Trading Co., Ltd. and Xerox Medical Products International Trading (Shanghai) Co., Ltd. all imported more than US$10 million. Higher than other companies.
Market prospects <br> <br> Currently, artificial joint replacement surgery have a more mature operation, it can eliminate joint pain, joint function return to normal activities, so that people affected by long-term joint pain and suffering of a new life again, surgery Afterwards, walking, traveling, working and physical exercises can be performed like normal people, so artificial joints have become one of the major best-selling products in the orthopedic device market.
Joint disease is a common disease in the elderly. Through joint replacement surgery, many elderly people have regained confidence in life and have effectively improved their quality of life. As the global population ages, the demand for artificial joints is increasing. At the same time, the number of joint traumas caused by intense sports and traffic accidents is increasing every year. The demand for artificial joint products required for treatment is increasing day by day, and the artificial joint market is developing at an unprecedented rate.
With the development of science and technology, artificial joint materials have evolved from early wear-resistant stainless steel joints to today's high-performance materials such as silicon carbide and other high-hardness ceramic materials, aerospace ceramic materials, and aluminum-zirconium alloy materials. The artificial joints made of these high-performance materials have made the hardness, wear resistance, impact resistance, high temperature stability and biocompatibility of the products greatly improved. The weight is closer to the bones and joints, and the compatibility with the human body is even greater. it is good. The continuous improvement of safety and effectiveness further promotes the widespread use of artificial joints.
Quality of domestic products is expected to increase <br> <br> from the domestic market share of view, according to incomplete statistics, in 2011 China's orthopedic surgeon has implemented a total of about 200,000 cases of arthroplasty, in this process, hospitals are more Products of foreign companies such as Johnson & Johnson, Zimmer and Xerox. At present, imported products account for more than 60% of the market share of artificial joints in China.
Compared with domestic products, the functionality and effectiveness of imported products are higher, but the price is relatively expensive, the price is often 2 to 3 times that of similar domestic products, such as domestic artificial hip joints price of about 20,000 to 30,000 yuan , imports are 40,000 to 50,000 yuan. From the perspective of clinical application, some imported products are designed according to the anatomical and physiological characteristics of European and American races, and there is a problem of mismatching with patients' bones in clinical applications in China. This will increase the difficulty of operation and increase the time, and increase the number of doctors and patients. Risk, to a certain extent, affects the effectiveness of clinical treatment.
In June 2011, the “12th Five-Year Plan†national high-tech research and development program in the field of new materials technology “The research and development of key materials technology for the replacement and repair of typical human organ tissues†has been approved by the Ministry of Science and Technology. The project content includes the titanium alloy artificial Key technologies and product R&D for joints and traumatic materials are designed to break through the key technologies of design, processing, surface modification and large-scale production to develop economical, practical and reliable products that meet the physiological characteristics of Chinese people and reduce product prices. Fully independent intellectual property rights artificial joint industry chain.
The development of local brands has continued since 2000. With the rigid demand of the market, the market for artificial joints in China has grown rapidly. Local companies have already achieved the first step of differentiation in the early stages, and a number of representative companies have emerged, such as Chuangsheng, Kanghui and Weiwei. These companies are based on The mid-end market gradually penetrates the high-end market and continues to extend its product lines to overseas markets.
At present, on the one hand, China's artificial joint production enterprises should increase research and development efforts, strengthen cooperation with universities and research institutions, and jointly apply for government support and support in funds and policies, and strive to establish new materials and new processes in the product. Advantages; On the other hand, companies should listen to doctors and patients' suggestions and opinions, encourage them to directly participate in product development, and make products more in line with patient characteristics and disease characteristics. At the same time, the protection of intellectual property rights has been strengthened, and on the basis of ensuring that independent brands are not harmed, and using the price competition of their own products and geographical location advantages, they have actively explored markets in Africa and Asia and established long-term cooperative relationships with medical institutions in some countries. The market takes the initiative.
Artificial joint global growth in foreign trade flat <br> <br> In recent years, artificial joint global trade import and export growth rate is very rapid. From 2007 to 2011, the average annual growth rate of artificial joint imports was 11.02%, and the average annual growth rate of exports was 12.4%.
From the perspective of importing countries, in 2011, a total of 13 countries had imported more than 100 million U.S. dollars, namely the United States, Germany, Belgium, France, Japan, Switzerland, Italy, the Netherlands, the United Kingdom, Australia, Spain, Canada, and South Korea. From the perspective of exporting countries, a total of nine countries in the world have exported more than 100 million U.S. dollars, including the United States, Belgium, Germany, Switzerland, Ireland, France, the United Kingdom, the Netherlands, and Italy.
The first half of 2012 exports of artificial joints <br> <br> Belgium is the largest export market for the region, China's exports to the amount of artificial joints Europe amounted to $ 34.068 million, 91.57% of the total amount for the first outlet market. From the perspective of specific countries and regions, China has exported artificial joints to 32 countries and regions. The total value of the top ten trading partners reached US$36.735 million, accounting for 98.74%. Belgium is China's first export partner, and its export value reached 270.707 million US dollars, accounting for 72.76% of the total amount.
Jiangsu's exports account for 80%. From the perspective of exporting provinces and cities, China's provinces and cities that export artificial joints are relatively concentrated, and only 8 provinces and cities export artificial joints. Although only three companies in Jiangsu Province ranked first in terms of export value, their total exports amounted to US$ 29.9089 million, accounting for 80.12% of the national export volume, reflecting the high degree of concentration in export regions. From the perspective of growth rate, the growth rates in Beijing, Henan, and Guangdong are more obvious.
Foreign-funded enterprises are the main force for exports. Among the 31 companies that engage in artificial joint export trade, 12 are foreign-funded enterprises with an export value of 35,548,900 U.S. dollars, accounting for 95.55% of the total export value; 12 private enterprises, export value of 0.959 million U.S. dollars, accounting for the total 2.58% of the export value; seven state-owned enterprises, the export value of 69.55 million US dollars, accounting for 1.87% of total exports.
The first advantage is that the export value of the top ten enterprises in the export market totals US$3,603.03 million, accounting for 97.6% of the total export value. Among them, the number one exporter of Johnson & Johnson (Suzhou) Medical Equipment Co., Ltd. has exceeded US$20 million in export volume. Far more than other companies. Among the remaining 30 companies, only Xi'an Antai Blade Technology Co., Ltd., Changzhou Baomeite Medical Devices Co., Ltd. and Linker Orthopedics (China) Co., Ltd. have exported more than US$1 million.
Increase in the Import Volume of Imported Artificial Joints in China From 2007 to 2011, the import and export trade of artificial joints in China witnessed a rapid development. The export value increased from US$3.834 million to US$51.72 million, and the import value increased even more, from US$60.943 million to US$131 million. The trade deficit widened from 57.109 million US dollars to 79.646 million US dollars. From January to June 2012, China's artificial joint import and export volume reached 143 million U.S. dollars, of which export value was 37.2304 million U.S. dollars, an increase of 56.76% year-on-year, and import value was 106 million U.S. dollars, an increase of 46.43% year-on-year.
The first half of 2012, imports of artificial joints <br> <br> United States and Germany are the two major import markets of Europe and North America from imported artificial joint amounted to $ 42,394,500 and $ 56,400,900, respectively of the total imports of 40.03% And 53.26%.
From the perspective of specific countries and regions, China has imported artificial joint products from 17 countries and regions. The United States, Germany and Switzerland are the main import trading partners. From the perspective of growth rate, the growth rates of the United States and Switzerland are significant, reaching as high as 120.31% and 125.52% respectively.
Shanghai's imports ranked first. From the perspective of imported provinces and cities, Shanghai, Beijing, Jiangsu, Sichuan, Hubei, Guangdong, Henan, Shandong, and Liaoning have imported artificial joints in 9 provinces and cities. The total import value of 25 enterprises in Shanghai totaled 74,190,300 US dollars, and the number and amount of imported companies ranked first in the country.
Foreign-funded enterprises as import leaders China has a total of 58 companies engaged in artificial joint import trade, including 24 foreign-funded enterprises, with an import value of 77.537 million US dollars, accounting for 73.22% of the total import value; 12 state-owned enterprises, import value of 23.7747 million US dollars, accounting for the total 22.45% of the import value; 22 private enterprises, with an import value of 4,599,100 USD, accounting for 4.33% of the total import value.
The top ten largest importers of the top four companies imported a total of US$90.1313 million worth of imports, accounting for 90.67% of the total imports. Johnson & Johnson (Shanghai) Medical Equipment Co., Ltd., Beijing Wei Lian De Orthopedics Technology Co., Ltd., Zimmer (Shanghai) Medical International Trading Co., Ltd. and Xerox Medical Products International Trading (Shanghai) Co., Ltd. all imported more than US$10 million. Higher than other companies.
Recliner Chairs,Small Recliner Chair,Recliner Chair Sale,Cheap Recliner Chairs
Jiangyin Kaili Health-Care Equipment CO., LTD. , https://www.kailimed.com